Major Depressive Disorder Industry Pipeline Insights, 2017 Major Depressive Disorder Market | Page 2















A review of the marketed products under prescription for Major Depressive Disorder, regulatory
information and marketing status.
Coverage of global patent coverage and detailed commentaries on the US patent challenges.
Graphical representation of investigational products for patent expiry and market exclusivities across
the globe.
Product profiles for marketed products for Major Depressive Disorder with complete description of
mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
Coverage of API Manufacturers for Major Depressive Disorder drugs in the United States, Europe and
Asian Regions with location details.
Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Major
Depressive Disorder drugs.
Key discontinued Marketed products.
Global Sales Figure from 2012-2016.Reasons to Buy
Evaluate the marketing status and exclusivity details of Major Depressive Disorder key products to
exploit opportunities for generic drug development opportunities.
Key players in the pharmaceutical industry.
Strategic drivers and restraints of this market are revealed and market opportunities and challenges are
identified.
Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry
details and exclusivity with respect to Major Depressive Disorder.
API intelligence over marketed drugs for Major Depressive Disorder and gaining primary intelligence
over active ingredients manufacturers across the globe.
Uncovering opportunities in the rapidly growing the US markets.
Major Depressive Disorder Table of Contents
1.
2.
3.
4.
5.
6.
7.
8.
9.
Indication Overview
Marketed Drugs Assessment
Marketed Details of Drugs by Application Type
Marketed Details of Drugs (NDA) by Marketing Status
Marketed Details of Drugs by Patent Expiration Timeline
The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
The API Manufacturers by the United States Drug Master File (US DMF) Status
The API Manufacturers by the US DMF Status (Drug Specific)
Drugs Market Data and Sales Figures (2012-2016)